Related Articles
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Heterogeneous methylation of the O6-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines
Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation
The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcoma
Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas